Trevi Therapeutics (TRVI) Cash & Equivalents (2018 - 2026)
Trevi Therapeutics' Cash & Equivalents was $54.3 million in Q2 2026, down 53.6% from $117.06 million a year earlier but up 179.7% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Trevi Therapeutics came in at $18.91 million, down 44.5% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $34.1 million in FY2024 (+5.2%), $32.4 million in FY2023 (+157.3%), $12.59 million in FY2022 (-65.8%) and $36.83 million in FY2021 (-18.2%).
- Quarterly Cash & Equivalents has moved between $11.65 million (Q1 2023) and $117.06 million (Q2 2025) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 120.8%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2025 (growth of 803.0%); the worst was Q4 2022 (a decline of 65.8%).
- Per Business Quant data, TRVI's Cash & Equivalents in the three quarters before Q2 2026 was $19.41 million (Q1 2026), $18.91 million (Q4 2025) and $56.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 2.02 Bn | - | 54.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.30 Mn |
| Mar 31, 2026 | 19.41 Mn |
| Dec 31, 2025 | 18.91 Mn |
| Sep 30, 2025 | 56.87 Mn |
| Jun 30, 2025 | 117.06 Mn |
| Mar 31, 2025 | 19.37 Mn |
| Dec 31, 2024 | 34.10 Mn |
| Sep 30, 2024 | 16.05 Mn |
| Jun 30, 2024 | 12.96 Mn |
| Mar 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 32.40 Mn |
| Sep 30, 2023 | 25.97 Mn |
| Jun 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 11.65 Mn |
| Dec 31, 2022 | 12.59 Mn |
| Sep 30, 2022 | 66.57 Mn |
| Jun 30, 2022 | 24.70 Mn |
| Mar 31, 2022 | 29.11 Mn |
| Dec 31, 2021 | 36.83 Mn |
| Sep 30, 2021 | 29.32 Mn |
API Access
Trevi Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();